J Korean Rheum Assoc.
1995 Jan;2(1):87-91.
A Case Of D-Penicillamine Induced Polymyositis
- Affiliations
-
- 1Rheumatism Center, Department of Internal Medicine, College of Medicine, Hanyang University, Seoul, Korea.
Abstract
- Polymyositis can develop infrequently as one of the autoimmune complications of D-penicillamine treatment, but its exact pathogenesis remains unclear. Suspicion of D-penicillamine induced polymyositis should be followed by immediate drug withdrawal and confirmation of diagnosis by determination of muscle enzymes, EMG and biopsy. Most patients recover from polymyositis completely within 6 months after drug withdrawal, even though steroid may be used in severe conditions. Suspicion of pre-existing low-grade myopathy or myositis should possibly be regarded as a relative contraindication to D-penicillamine treatment and analysis of muscle enzymes should be followed regularly. We experienced a case of rheumatoid arthritis who developed polymyositis after treatment of D-penicillamine for about 5 weeks(total dosage 3500mg) in a 47-year-old female and report this with a review of literature.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of D-Penicillamine Induced Iga Nephropathy in a Patients with Scleroderma
- D-penicillamine Induced Elastosis Perforans Serpiginosa
- Bucillamine-Induced Pemphigus Vulgaris in a Patient with Rheumatoid Arthritis and Polymyositis Overlap Syndrome
- Polymyositis in a Primary Biliary Cirrhotic Patient Treated with D-penicillamine
- A case of aplastic anemia induced by D-penicillamine
